Authors: Representative Wes Culver
Co-authors: Representative Steven Davisson, Representative Charlie Brown, Representative Edward Clere
Sponsors: Senator Ed Charbonneau, Senator Patricia Miller, Senator Jean Breaux
Co-Sponsors: Senator Ronald Grooms, Senator Chip Perfect, Senator Brandt Hershman, Senator Brent Steele
Provides that a manufacturer of an investigational drug, biological product, or device may make the drug, biological product, or device available to a patient who meets certain requirements. Adds to the requirements concerning experimental or nonconventional medical treatment and the authority to allow a patient to receive an experimental or nonconventional medical treatment if a physician determines that the patient: (1) has been diagnosed with a terminal disease or condition; and (2) does not have comparable or satisfactory treatment options. Specifies that a new cause of action is not created. Makes a technical correction.